Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin beta 5 (ITGB5) functions as a subunit of integrins, which are transmembrane receptors involved in cell adhesion and signaling. It combines with alpha chains, notably alpha-V (ITGAV), to form heterodimeric integrins like αVβ5, acting as a receptor for extracellular matrix proteins such as fibronectin and vitronectin. It plays roles in cell adhesion, signaling pathways regulating apoptosis and migration, and is implicated in tumor progression and metastasis. ITGB5 interacts with proteins like PTK2, Annexin A5, and PAK4, influencing downstream signaling events. Elevated levels are observed in osteopetrosis, and genetic association studies link it to Parkinson's and villous adenocarcinoma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin beta 5 (ITGB5).